These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25359339)

  • 1. Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment.
    Roche N; Jebrak G; Caillaud D; Deslée G; Brinchault G; Chanez P; Court-Fortune I; Escamilla R; Nesme-Meyer P; Pinet C; Carré P; Paillasseur JL; Perez T; Burgel PR;
    Eur Respir J; 2015 Jan; 45(1):260-2. PubMed ID: 25359339
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
    Jones PW
    Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
    Jahnz-Różyk K; Szepiel P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
    Beeh KM; Westerman J; Kirsten AM; Hébert J; Grönke L; Hamilton A; Tetzlaff K; Derom E
    Pulm Pharmacol Ther; 2015 Jun; 32():53-9. PubMed ID: 25956072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affirmation of the adoration of the vagi and role of tiotropium in asthmatic patients.
    Gelb AF; Nadel JA
    J Allergy Clin Immunol; 2016 Oct; 138(4):1011-1013. PubMed ID: 27527265
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Busch-Petersen J; Lainé DI
    Future Med Chem; 2011 Oct; 3(13):1623-34. PubMed ID: 21942252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.
    Vogelmeier C; Banerji D
    Ther Adv Respir Dis; 2011 Jun; 5(3):163-73. PubMed ID: 21511677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
    Maltais F; Milot J
    Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.
    Bulkhi A; Tabatabaian F; Casale TB
    Drugs; 2016 Jul; 76(10):999-1013. PubMed ID: 27289376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].
    Ulrik CS
    Ugeskr Laeger; 2013 Aug; 175(35):1946-8. PubMed ID: 23978116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscarinic cholinergic receptor antagonists enhanced the expression of CD(8)(+)CD(25)(+)Foxp(3)(+) regulatory T cells in stable COPD patients].
    Zhang JC; Wang P; Xiong XZ; Deng L; Xin JB; Ma WL; Shi HZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):33-6. PubMed ID: 20368022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor.
    Buigues PJ; Gehrke S; Badaoui M; Dudas B; Mandana G; Qi T; Bottegoni G; Rosta E
    J Chem Theory Comput; 2023 Aug; 19(15):5260-5272. PubMed ID: 37458730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Page CP; Matera MG
    Expert Opin Pharmacother; 2013 Jun; 14(9):1205-14. PubMed ID: 23566013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ▾Glycopyrronium for COPD.
    Drug Ther Bull; 2013 Jun; 51(6):66-8. PubMed ID: 23744364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD.
    Cazzola M
    Curr Opin Investig Drugs; 2009 May; 10(5):482-90. PubMed ID: 19431081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends.
    Montuschi P; Ciabattoni G
    J Med Chem; 2015 May; 58(10):4131-64. PubMed ID: 25587755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.
    Babu KS; Morjaria JB
    Ther Adv Respir Dis; 2015 Apr; 9(2):56-68. PubMed ID: 25754881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.